|
1
|
Chen X, Ma S and Zhang Z: Analysis of
clinical characteristics of pancreatic carcinoma in northern China.
Pancreas. 39:1116–1118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
4
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar
|
|
5
|
Ruan K, Fang X and Ouyang G: microRNAs:
novel regulators in the hallmarks of human cancer. Cancer Lett.
285:116–126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hrašovec S and Glavač D: microRNAs as
Novel Biomarkers in Colorectal Cancer. Front Genet. 3:1802012.
|
|
7
|
Chen PS, Su JL and Hung MC: Dysregulation
of microRNAs in cancer. J Biomed Sci. 19:902012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu H: microRNAs in breast cancer
initiation and progression. Cell Mol Life Sci. 69:3587–3599. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Poy MN, Eliasson L, Krutzfeldt J, et al: A
pancreatic islet-specific microRNA regulates insulin secretion.
Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang WH, Gui JH, Wang CZ, et al: The
identification of miR-375 as a potential biomarker in distal
gastric adenocarcinoma. Oncol Res. 20:139–147. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chang Y, Yan W, He X, et al: miR-375
inhibits autophagy and reduces viability of hepatocellular
carcinoma cells under hypoxic conditions. Gastroenterology.
143:177–187.8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dai X, Chiang Y, Wang Z, et al: Expression
levels of microRNA-375 in colorectal carcinoma. Mol Med Rep.
5:1299–1304. 2012.PubMed/NCBI
|
|
13
|
Raimondi C and Falasca M: Targeting PDK1
in cancer. Curr Med Chem. 18:2763–2769. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Westmoreland JJ, Wang Q, Bouzaffour M,
Baker SJ and Sosa-Pineda B: Pdk1 activity controls proliferation,
survival, and growth of developing pancreatic cells. Dev Biol.
334:285–298. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nikitina EG, Urazova LN and Stegny VN:
microRNAs and human cancer. Exp Oncol. 34:2–8. 2012.
|
|
16
|
He XX, Chang Y, Meng FY, et al:
microRNA-375 targets AEG-1 in hepatocellular carcinoma and
suppresses liver cancer cell growth in vitro and in vivo. Oncogene.
31:3357–3369. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsukamoto Y, Nakada C, Noguchi T, et al:
microRNA-375 is downregulated in gastric carcinomas and regulates
cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res.
70:2339–2349. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen Y, Wang P, Li Y, et al: miR-375 is
upregulated in acquired paclitaxel resistance in cervical cancer.
Br J Cancer. 109:92–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garzon R, Calin GA and Croce CM: microRNAs
in Cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar
|
|
20
|
Liu AM, Poon RT and Luk JM: microRNA-375
targets Hippo-signaling effector YAP in liver cancer and inhibits
tumor properties. Biochem Biophys Res Commun. 394:623–627. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Lin R and Li J: Epigenetic silencing
of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig
Dis Sci. 56:2849–2856. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ding L, Xu Y, Zhang W, et al: MiR-375
frequently downregulated in gastric cancer inhibits cell
proliferation by targeting JAK2. Cell Res. 20:784–793. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nishikawa E, Osada H, Okazaki Y, et al:
miR-375 is activated by ASH1 and inhibits YAP1 in a
lineage-dependent manner in lung cancer. Cancer Res. 71:6165–6173.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Xing R, Zhang X, et al: miR-375
targets the p53 gene to regulate cellular response to ionizing
radiation and etoposide in gastric cancer cells. DNA Repair (Amst).
12:741–750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sheppard K, Kinross KM, Solomon B, Pearson
RB and Phillips WA: Targeting PI3 kinase/AKT/mTOR signaling in
cancer. Crit Rev Oncog. 17:69–95. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dhanasekaran DN and Johnson GL: MAPKs:
function, regulation, role in cancer and therapeutic targeting.
Oncogene. 26:3097–3099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang X, Yan Z, Zhang J, et al:
Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for
recurrence risk in gastric cancer patients following surgical
resection. Ann Oncol. 22:2257–2266. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Song J, Kim D, Chun CH and Jin EJ:
microRNA-375, a new regulator of cadherin-7, suppresses the
migration of chondrogenic progenitors. Cell Signal. 25:698–706.
2013. View Article : Google Scholar : PubMed/NCBI
|
